COMMUNIQUÉS West-GlobeNewswire

Curia Releases 2024 Environmental, Social and Governance (ESG) Report
28/10/2025
ALBANY, N.Y., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced the release of its third Environmental, Social and [...]
Former Amazon Care Executive Dr. Sunita Mishra Joins Heald’s Advisory Board to Accelerate Expansion Across Employers and Provider Networks
28/10/2025
ALPHARETTA, Ga., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Heald , the human-led, tech-enabled platform redefining Diabetes care, proudly announces that Dr. Sunita Mishra, former Chief Medical Officer of Amazon Health services [...]
Remedy's Nutrition® Launches Premium Horse Chestnut 1000mg Capsules to Support Vein Health and Healthy Circulation
28/10/2025
KEY LARGO, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Remedy's Nutrition®, a trusted natural dietary supplement company since 1972 and a leader in premium herbal formulations, today announced the launch of its high-potency [...]
Trethera Successfully Completes Phase 1 Dose Escalation Trial Demonstrating Broad Therapeutic Window, Favorable Safety, and Confirmed Target Engagement
28/10/2025
LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, today announced [...]
Novartis completes acquisition of Tourmaline Bio
28/10/2025
Basel, October 28, 2025 - Novartis today announced that it has successfully completed its acquisition of Tourmaline Bio, Inc. (“Tourmaline”). With the completion of the acquisition, shares of common stock, par value $0. [...]
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
28/10/2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Assertio Announces Leadership Transition
28/10/2025
Appoints Industry Veteran and Current Director Mark L. Reisenauer as CEO, Effective Immediately Company Will Report Third Quarter Results on November 10, 2025 and Expects to Update Guidance Within the Current Range at [...]
New Study Finds Online Tinnitus Course “Still Tinnitus” Effective
28/10/2025
Independent research shows that the self-paced “Still Tinnitus” course can help reduce tinnitus symptoms and improve quality of life for people with tinnitus worldwide. Amsterdam, The Netherlands, Oct. 28, 2025 (GLOBE [...]
Olympia Pharmaceuticals Strengthens National Presence, Bringing New Licensing to Mississippi
28/10/2025
The industry-leading 503B outsourcing facility grows its footprint to 49 states, offering expanded healthcare resources with a spotlight on Mississippi ORLANDO, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Olympia [...]
Sevaro Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups
28/10/2025
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- CB Insights named Sevaro Health to its seventh annual Digital Health 50, showcasing the 50 most promising private digital health companies in the world. “The 2025 Digital [...]
Sharecare awarded three-year NCQA Accreditation for Wellness and Health Promotion
28/10/2025
Accreditation for its lifestyle and disease management interventions complements Sharecare's existing three-year NCQA accreditations for Population Health Program and Case Management ATLANTA, Oct. 28, 2025 (GLOBE [...]
Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience
28/10/2025
ADELAIDE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Avance Clinical , the award-winning Australian led, global CRO built exclusively to service the clinical research needs of biotech companies, today announced the [...]
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
28/10/2025
Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications Company remains focused on advancing PALI-2108 [...]
Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer
28/10/2025
Karen Smith, MD, PhD, MBA, LLM, joins with over 25 years of global pharma and biotech experience, having contributed to more than 20 regulatory approvals Dr Smith's appointment will accelerate Step Pharma's ‘pipeline in [...]
SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial
28/10/2025
SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial SPVN20 aims to restore visual acuity and aspects of color vision by creating an alternative light-signaling cascade in [...]
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
28/10/2025
Study met primary and secondary endpoints Paridiprubart demonstrated a relative reduction in the risk of death of 25% Treatment provided patients with clinically meaningful improvement in survival and recovery [...]
BioNTech to Host Innovation Series R&D Day on November 11, 2025
28/10/2025
MAINZ, Germany, October 28 , 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), will host an edition of the Company’s Innovation Series R&D Day at 09:00 a.m. Eastern Standard Time (3: [...]
Evidence Against Evidence: CERN-IEEE FPGA vs. Crosetto 3D-Flow, a Breakthrough Invention Recognized 32 Years Ago That Could Have, and Can Still, Save Billions of Euros and Millions of Lives
28/10/2025
Science vs. Consensus: An urgent call to CERN, IEEE, and the scientific community to engage with verifiable evidence, fulfill scientific duty, and resolve contradictions based on the laws of nature, not institutional [...]
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
28/10/2025
– ARCALYST ® (rilonacept) Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth – – ARCALYST 2025 expected net product revenue raised to $670 - $675 million – – KPL-387 granted Orphan [...]

Pages